MedPath

Carbetocin Versus Oxytocin and Hemodynamic Effects

Phase 4
Completed
Conditions
Effects of; Anesthesia, in Pregnancy
Interventions
Registration Number
NCT00977769
Lead Sponsor
Oslo University Hospital
Brief Summary

A randomized double-blind trial of oxytocin 5 u, carbetocin 100 µg and placebo with hemodynamic response as a primary outcome measure.

Detailed Description

Healthy pregnant women sheduled for elective cesarean section. Invasive hemodynmaic monitoring with LiDCO Plus.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
76
Inclusion Criteria
  • Healthy pregnant women for planned cesarean section
Exclusion Criteria
  • Bleeding disorders
  • Placenta disorders

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
carbetocin 100 µgcarbetocin 100 µgCarbetocin injection, 100µg, single injection
oxytocin 5 uoxytocin 5 uOxytocin 5U, injection, single injection
placebo (NaCl)placebo (NaCl)Saline single injection
Primary Outcome Measures
NameTimeMethod
Cardiac Output2.5 minutes

The relative change in CO from baseline at the time of delivery up to 2.5 minutes post delivery.

Arterial Blood Pressure2.5 min

The mean change in SAP compared with baseline at the time of delivery up to 2.5 minutes post delivery.

Secondary Outcome Measures
NameTimeMethod
Bleeding120 minutes

The calculated estimated blood loss from delivery until 2 h after intervention

Trial Locations

Locations (2)

Division of Anesthesia and Intensive Care Medicine

🇳🇴

Oslo, Norway

Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet

🇳🇴

Oslo, Norway

© Copyright 2025. All Rights Reserved by MedPath